These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12134944)

  • 1. Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides.
    González Ferreiro M; Tillman LG; Hardee G; Bodmeier R
    Pharm Res; 2002 Jun; 19(6):755-64. PubMed ID: 12134944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers.
    González Ferreiro M; Tillman L; Hardee G; Bodmeier R
    Int J Pharm; 2002 Jun; 239(1-2):47-59. PubMed ID: 12052690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced delivery of bifidobacteria and fecal changes after multiple oral administrations of bifidobacteria-loaded alginate poly-l-lysine microparticles in human volunteers.
    Cui JH; Cao QR; Lee BJ
    Drug Deliv; 2007 Jul; 14(5):265-71. PubMed ID: 17613013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and stability of bifidobacteria loaded in alginate poly-l-lysine microparticles.
    Cui JH; Goh JS; Kim PH; Choi SH; Lee BJ
    Int J Pharm; 2000 Dec; 210(1-2):51-9. PubMed ID: 11163987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides.
    Aynié I; Vauthier C; Chacun H; Fattal E; Couvreur P
    Antisense Nucleic Acid Drug Dev; 1999 Jun; 9(3):301-12. PubMed ID: 10435755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Administration of Microparticulate Antisense Oligonucleotide (ASO) for the Treatment of Lung Inflammation.
    Ubale RV; Shastri PN; Oettinger C; D'Souza MJ
    AAPS PharmSciTech; 2018 May; 19(4):1908-1919. PubMed ID: 29663290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of complexes of an antisense oligonucleotide with protamine and poly-L-lysine salts.
    González Ferreiro M; Tillman L; Hardee G; Bodmeier R
    J Control Release; 2001 Jun; 73(2-3):381-90. PubMed ID: 11516513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characterization of calcium alginate microparticles coated with polycations as protein delivery system.
    Zarate J; Virdis L; Orive G; Igartua M; Hernández RM; Pedraz JL
    J Microencapsul; 2011; 28(7):614-20. PubMed ID: 21740107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.
    Greimel A; Werle M; Bernkop-Schnürch A
    J Pharm Pharmacol; 2007 Sep; 59(9):1191-8. PubMed ID: 17883889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system.
    Unagolla JM; Jayasuriya AC
    Eur J Pharm Sci; 2018 Mar; 114():199-209. PubMed ID: 29269322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system.
    Kim BY; Jeong JH; Park K; Kim JD
    J Control Release; 2005 Feb; 102(3):525-38. PubMed ID: 15681076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new non-viral DNA delivery vector: the terplex system.
    Kim JS; Kim BI; Maruyama A; Akaike T; Kim SW
    J Control Release; 1998 Apr; 53(1-3):175-82. PubMed ID: 9741925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilayer mucoadhesive microparticles for the delivery of metoprolol succinate: Formulation and evaluation.
    Kumar K; Dhawan N; Sharma H; Patwal PS; Vaidya S; Vaidya B
    Artif Cells Nanomed Biotechnol; 2015; 43(5):328-33. PubMed ID: 24579883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying.
    Möbus K; Siepmann J; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):121-30. PubMed ID: 22342605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field Effect Microparticle Generation for Cell Microencapsulation.
    Hsu BR; Fu SH
    Methods Mol Biol; 2017; 1479():57-70. PubMed ID: 27738926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation.
    Hou JY; Gao LN; Meng FY; Cui YL
    Mar Drugs; 2014 Dec; 12(12):5764-87. PubMed ID: 25470180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property.
    Yu CY; Yin BC; Zhang W; Cheng SX; Zhang XZ; Zhuo RX
    Colloids Surf B Biointerfaces; 2009 Feb; 68(2):245-9. PubMed ID: 19058952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
    Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
    J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic alpha,epsilon-poly(L-lysine)s as delivery agents for antisense oligonucleotides.
    Eom KD; Park SM; Tran HD; Kim MS; Yu RN; Yoo H
    Pharm Res; 2007 Aug; 24(8):1581-9. PubMed ID: 17373579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.